F-star splits from invoX after $161M acquisition in 2023
07 Apr 2025 //
FIERCE BIOTECH
invoX`s FS222 Shows Positive Phase 1 Data In Advanced Solid Tumors
03 Jun 2024 //
BUSINESSWIRE
invoX Pharma Increases Investment in pHion Therapeutics
01 Jun 2023 //
BUSINESSWIRE
InvoX Pharma’s F-star Announces Licence Agreement With Takeda
22 Mar 2023 //
BUSINESSWIRE
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
08 Mar 2023 //
BUSINESSWIRE
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX
07 Mar 2023 //
GLOBENEWSWIRE